Rong-zhen Li

FGF9 inhibition by a novel binding peptide has efficacy in gastric and bladder cancer per se and reverses resistance to cisplatin.

Jizhong Wang, Xiangpeng Tan, Qiuxiao Guo, 2019, Pharmacological research.

CircSCAP interacts with SF3A3 to inhibit the malignance of non-small cell lung cancer by activating p53 signaling

Hui-Yun Wang, Rong-zhen Li, Dongni Chen, 2022, Journal of experimental & clinical cancer research : CR.

A short peptide reverses the aggressive phenotype of prostate cancer cells

Xiao-mian Lin, Yi-shan Huang, Lian-kuai Chen, 2018, European journal of pharmacology.